Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Galloway, James; L Hyrich, Kimme; Mercer, Louise; G Dixon, William; Fu, Bo; Ustianowski, Andrew; Watson, Kath; Lunt, Mark; Symmons, Deborah; behalf of the British Society for Rheumatology Biologics Register, on

doi:10.1093/rheumatology/keq242

Public

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Published in Lara D. Veeken • Jul 31, 2010

Authors:

James Galloway

Kimme L Hyrich

Louise Mercer

Abstract

OBJECTIVES: To evaluate the risk of serious infections (SIs) in patients with RA treated with anti-TNF therapy with emphasis on the risk across different ages. METHODS: Using data from the British Society for Rheumatology Biologics Register, a prospective observational study, we compared the risk of...

Subject

Medicine

Etanercept

Adalimumab

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!